Françoise Boyer

Myeloproliferative Neoplasm (MPN) Symptom Assessment Form Total Symptom Score: Prospective International Assessment of an Abbreviated Symptom Burden Scoring System Among Patients With MPNs

Robyn M. Emanuel, Amylou C. Dueck, Holly L. Geyer et al. · Journal of Clinical Oncology · 2012 · 441 citations · Full text

Practical application and clinical impact of the WHO histopathological criteria on bone marrow biopsy for the diagnosis of essential thrombocythemia versus prefibrotic primary myelofibrosis

Maud Brousseau, Elsa Parot‐Schinkel, Marie‐Pierre Moles et al. · Histopathology · 2010 · 71 citations

Genomic analysis of primary and secondary myelofibrosis redefines the prognostic impact of <i>ASXL1</i> mutations: a FIM study

Damien Luque Paz, Jérémie Riou, Emmanuelle Verger et al. · Blood Advances · 2021 · 70 citations · Full text

Leukemic evolution of polycythemia vera and essential thrombocythemia: genomic profiles predict time to transformation

Damien Luque Paz, Rébecca Jouanneau‐Courville, Jérémie Riou et al. · Blood Advances · 2020 · 67 citations · Full text

Associations between gender, disease features and symptom burden in patients with myeloproliferative neoplasms: an analysis by the MPN QOL International Working Group

Holly L. Geyer, Heidi Kosiorek, Amylou C. Dueck et al. · Haematologica · 2016 · 66 citations · Full text

Symptom Burden, Thrombosis, Polycythemia Vera +13